Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes (Q33209301)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes |
scientific article |
Statements
1 reference
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes (English)
1 reference
Bo Ahrén
1 reference
Ramon Gomis
1 reference
Eberhard Standl
1 reference
David Mills
1 reference
Anja Schweizer
1 reference
1 December 2004
1 reference
Identifiers
1 reference